Status: Not yet recruiting
Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing
Ketamine is a medicine used in psychiatry for treatment-resistant depression. This study compares two ways of framing ketamine treatment: a psychedelic framing and a biomedical framing. The study will examine whether the framing affects depressive symptoms, treatment experience, tolerability, and longer-term outcomes.
Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Valdemar LandgrenUpdated: Sep 17, 2026Locations: 1
Eligibility criteria
Prescribed ketamine treatment for depression [+1]